• Full Text
  • Scholarly Journal

Drug Repurposing to Identify a Synergistic High-Order Drug Combination to Treat Sunitinib-Resistant Renal Cell Carcinoma

; et al.
. 
; Basel Vol. 13, Iss. 16,  (2021): 3978.
DOI:10.3390/cancers13163978